Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

NHS patient care ‘will worsen’

October 4, 2012 Sales and Marketing A&E, MRSA, NHS, king's fund

Patient care will worsen over the next few years and the NHS will not meet its £20 billion productivity target …
News

Sanofi acquires leading Colombian firm

October 4, 2012 Sales and Marketing Columbia, Genfar, Latin America, Sanofi

Sanofi is expanding its presence in Latin American with the acquisition of a Colombian pharma company. Genfar is headquartered in …
News

GW Pharmaceuticals hires chief operating officer

October 4, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Chris Tovey, GW Pharmaceuticals

GW Pharmaceuticals has announced the appointment of Christopher John Tovey to the newly created position of chief operating officer. Tovey, …
Appointment

Seebri Breezhaler approved in Europe

October 4, 2012 Sales and Marketing COPD, Novartis, Relvar, Seebri Breezhaler, Tudorza

Novartis has been given approval in Europe for its Seebri Breezhaler to be used as maintenance treatment for chronic obstructive …
News

Patent losses force change for Sanofi

October 3, 2012 Sales and Marketing Avapro, BMS, Plavix, Sanofi, patent loss

Patent expiries are behind the decision by Sanofi and Bristol-Myers Squibb to radically restructure their long-term corporate alliance. The loss …
News

Non-executive directors of NHS Trust appointed

October 3, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Christine Beasley, NHS, Sarah Harkness

Christine Beasley and Sarah Harkness have been confirmed as non-executive directors of the NHS Trust Development Authority.  Ms Beasley (pictured) …
Appointment

Bayer signs endometriosis pact

October 3, 2012 Research and Development, Sales and Marketing Bayer, Evotec, endometriosis

Bayer HealthCare and Evotec have signed a five-year deal to look for three novel drugs to treat women with endometriosis. …
News

Is it really safety first?

October 2, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Les Rose, Roche

The idea of ensuring that drugs are adequately safe is not very old. Legislation that covers drug safety to the …
Feature

Survival boost for Votrient in mRCC

October 2, 2012 Research and Development, Sales and Marketing GSK, Nexavar, Pfizer, Sutent, Votrient

GlaxoSmithKline’s renal cell carcinoma drug Votrient has proved itself non-inferior to a bitter rival, Pfizer’s Sutent, in terms of progression-free …
News

Government launches Healthwatch England

October 2, 2012 Sales and Marketing HealthWatch, NHS, government

The government has launched Healthwatch England, a new statutory body whose role is to ensure the public’s voice is heard …
News

J&J cancer drugs get EU approval

October 2, 2012 Sales and Marketing Cancer, Dacogen, EU, J&J, JJ, Velcade

Two of Johnson & Johnson’s key cancer drugs have been shown the green light from the European Commission. Janssen-Cilag International’s …
News

BMS highlights Yervoy survival data

October 1, 2012 Research and Development, Sales and Marketing BMS, Roche, Yervoy, Zelboraf

Bristol-Myers Squibb’s melanoma drug Yervoy helps patients survive for longer than if they are receiving standard chemotherapy alone, according to …
News

Sanofi appoints Paul Chew as chief medical officer

October 1, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Paul Chew, Sanofi

Sanofi has appointed Dr Paul Chew as chief medical officer and head of global medical affairs. Taking up his post …
Appointment

FDA approves Bayer’s Stivarga

October 1, 2012 Research and Development, Sales and Marketing Bayer, FDA, KRAS, Roche, Stivarga, avastin

The FDA has approved Bayer HealthCare’s oncology pill Stivarga to treat patients with metastatic colorectal cancer (mCRC) whose disease has …
News

Merck gives back vernakalant rights

September 28, 2012 Sales and Marketing AF, Cardiome, Merck, vernakalant

Merck has dealt a further blow to Cardiome Pharma Corp by handing back all marketing and development rights for the …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026